N, J., D, H., FH, C., G, P., DA, C., A, R., . . . RE, L. (2023). Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: A sub-study of the Add-Aspirin trial. British journal of cancer, 129(4), 706. https://doi.org/10.1038/s41416-023-02310-1
Chicago Style (17th ed.) CitationN, Joharatnam-Hogan, et al. "Thromboxane Biosynthesis in Cancer Patients and Its Inhibition by Aspirin: A Sub-study of the Add-Aspirin Trial." British Journal of Cancer 129, no. 4 (2023): 706. https://doi.org/10.1038/s41416-023-02310-1.
MLA (9th ed.) CitationN, Joharatnam-Hogan, et al. "Thromboxane Biosynthesis in Cancer Patients and Its Inhibition by Aspirin: A Sub-study of the Add-Aspirin Trial." British Journal of Cancer, vol. 129, no. 4, 2023, p. 706, https://doi.org/10.1038/s41416-023-02310-1.